ArticleCureus2024
Prevalence and Characteristics of Dyslipidemia in a Hospital in Madagascar.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- [Prevalence of dyslipidemias in the biochemistry laboratory of Joseph Ravoahangy-Andrianavalona Hospital in Antananarivo, Madagascar].The Pan African medical journal · 2026Article
- Patterns of Morbidity in Ambatoboeny District, Northern Madagascar: A 12-Month Study.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Dyslipidemia is a major risk factor for atherosclerosis and is included in the metabolic syndrome. Data on dyslipidemia are still lacking in some parts of Africa. Our objectives were to report the prevalence of dyslipidemia and to describe the lipid profile of patients in a hospital in Madagascar. Materials and methods This was a descriptive cross-sectional study of patients admitted to the medical departments of Mahavoky Atsimo Hospital in Mahajanga, Madagascar, and followed for a period of 15 months. To be eligible, patients had to be over 18 years of age, have a lipid panel including total cholesterol, triglycerides, HDL, and LDL cholesterol, and agree to participate in the study. Results Of the 384 patients included in the study, 262 patients (68.23%) had dyslipidemia. The prevalence of dyslipidemia was 61.45% (n = 102) in men and 73.39% (n = 160) in women. In patients older than 65 years, the prevalence was 70.64% (n = 77). The different types of dyslipidemia were distributed as follows: hypercholesterolemia (24.22%, n = 93), hypo-HDL cholesterolemia (22.4%, n = 86), mixed hyperlipidemia (7.81%, n = 30), hyper-LDL cholesterolemia (7.29%, n = 28), and hypertriglyceridemia (6.51%, n = 25). Female gender (p = 0.013), diabetes mellitus (p = 0.007), and morbid obesity (p = 0.036) were associated with dyslipidemia. Conclusion The prevalence of dyslipidemia was high. Pure hypercholesterolemia and hypo-HDL-c were the most common types. Female gender, diabetes mellitus, and morbid obesity were associated with dyslipidemia. Prevention and treatment programs are essential to reduce the prevalence of dyslipidemia and the risk of cardiovascular events in low-income countries.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.